T2 Biosystems, Inc.·4

Feb 25, 3:39 PM ET

McDonough John 4

4 · T2 Biosystems, Inc. · Filed Feb 25, 2019

Insider Transaction Report

Form 4
Period: 2019-02-21
McDonough John
DirectorPresident & CEO
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-02-21+200,000200,000 total
    Exercise: $3.72Exp: 2029-02-21Common Stock (200,000 underlying)
  • Award

    Restricted Stock Units

    2019-02-21+100,000100,000 total
    Common Stock (100,000 underlying)
Footnotes (3)
  • [F1]The stock option vests in 48 equal monthly installments commencing February 21, 2019.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F3]The restricted stock units vest in three equal annual installments commencing February 21, 2020.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION